tm
Seeing Is Believing
tm
Seeing Is Believing
APLS is currently covered by 19 analysts with an average price target of $63.37. This is a potential upside of $15.91 (33.52%) from yesterday's end of day stock price of $47.46.
Apellis Pharmaceuticals's activity chart (see below) currently has 144 price targets and 206 ratings on display. The stock rating distribution of APLS is 72.17% BUY and 27.83% HOLD.
Analysts average stock forecasts to be materialized ratio is 73.58% with an average time for these price targets to be met of 212.1 days.
Highest price target for APLS is $106, Lowest price target is $46, average price target is $63.37.
Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 29-Apr-2024. First documented stock forecast 04-Dec-2017.
Currently out of the existing stock ratings of APLS, 83 are a BUY (72.17%), 32 are a HOLD (27.83%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
52
$4.54 (9.57%)
60
5 days ago
2/5 (40%)
$2.14 (4.29%)
15
Buy
92
$44.54 (93.85%)
92
8 days ago
3/15 (20%)
$42.14 (84.52%)
108
Buy
85
$37.54 (79.10%)
75
9 days ago
10/13 (76.92%)
$37.07 (77.34%)
230
Hold
57
$9.54 (20.10%)
67
17 days ago
14/17 (82.35%)
$8.97 (18.68%)
125
Buy
89
$41.54 (87.53%)
64
2 months ago
5/6 (83.33%)
$24.37 (37.71%)
391
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?
